“Formulary”

28 result(s)
Drug Pipeline
Promising Treatments for Alopecia Areata in the Pipeline
New Treatments for Alopecia Areata on the Horizon More
Briefing
Drug Pipeline
Keeping an Eye on the Drug Pipeline
New Drugs for Ophthalmic Disorders on the Horizon More
Briefing
Cost Management
2023 CVS Caremark Formulary Updates
CVS Caremark Announces Formulary Changes for 2023 More
Briefing
Cost Management
Reducing Wasteful Spend on High-Cost, Low-Value Drugs
CVS Health’s Hyperinflation Strategy Helps Clients Reduce Unnecessary Drug Spend More
Briefing
Cost Management
2022 CVS Caremark Formulary Updates
2022 CVS Caremark Formulary Updates Deliver Exceptional Value and Cost Management More
Briefing
Cost Management
Specialty Spend: Balancing Affordability and Member Experience
Payor strategies for specialty drug spend must strike a balance between affordability and member experience. More
Commentary
Cost Management
Eliminating Wasteful Spend on Hyperinflated Drugs
As part of the CVS Health hyperinflation strategy, our Outlier Pharmacy Program proactively monitors and identifies pharmacies with increased volume in claims submissions of... More
Briefing
Cost Management
2021 CVS Caremark Formulary Updates
Changes to CVS Caremark template formularies effective January 1, 2021 continue our legacy of innovation as well as delivering value and quality care — helping clients save money... More
Briefing
Cost Management
Achieving Cost Control Goals in the "New Normal"
Purpose-built formulary management and network management strategies from CVS Health are designed to help lower plan costs with minimal member disruption. More
Briefing
Cost Management
Blunting the Impact of Hyperinflated Drugs
Payors are projected to save on per-member-per-month costs from strategic formulary removals designed to help mitigate the effect of high-cost and hyperinflationary drugs More
Briefing